Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
Lyell Immunopharma, Inc. (LYEL)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
08/15/2023
Klausner Richard
Director
Sale
Common Stock
58k
$2.28
$132.3k
Grantor
08/15/2023
08/10/2023
Lang Matthew
Chief Business Officer
Grant
Option (right to buy)
2.2M
$2.31
$5.2M
08/10/2023
02/24/2023
Thompson Rahsaan
Chief Legal Officer
Grant
Option (right to buy)
245k
$2.13
$521.8k
02/24/2023
02/24/2023
Newton Charles W.
CFO
Grant
Option (right to buy)
700k
$2.13
$1.5M
02/24/2023
02/24/2023
Hill Stephen J.
Chief Technical Ops. Officer
Grant
Option (right to buy)
900k
$2.13
$1.9M
02/24/2023
02/24/2023
Lee Gary K.
Chief Scientific Officer
Grant
Option (right to buy)
600k
$2.13
$1.3M
02/24/2023
02/24/2023
Albertson Tina M.
Chief Medical Officer
Grant
Option (right to buy)
700k
$2.13
$1.5M
02/24/2023
12/15/2022
Seely Lynn
President and CEO
Grant
Option (right to buy)
7.5M
$3.28
$24.6M
12/15/2022
10/10/2022
Thompson Rahsaan
Chief Legal Officer
Grant
Option (right to buy)
715k
$6.91
$4.9M
10/10/2022
09/23/2022
Klausner Richard
Director
Sale
Common Stock
11.1k
$6.40
$71k
Grantor
09/23/2022
09/08/2022
Bishop Hans Edgar
Director
Exercise
Option (right to buy)
145.4k
$0.10
$14.5k
09/08/2022
06/08/2022
Bishop Hans Edgar
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
BRAWLEY OTIS W
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
NABEL ELIZABETH G
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
NELSEN ROBERT
10% Owner
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
RIEFLIN WILLIAM JL
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
Seely Lynn
President and CEO
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
FRIEDMAN CATHY
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2022
06/08/2022
Klausner Richard
Director
Grant
Option (right to buy)
65k
$5.31
$345.2k
06/08/2021
03/16/2022
Hill Stephen J.
Chief Technical Ops. Officer
Grant
Option (right to buy)
700k
$5.98
$4.2M
03/16/2022
03/16/2022
Homans Elizabeth
CEO
Grant
Option (right to buy)
1.5M
$5.98
$8.8M
03/16/2022
03/16/2022
Newton Charles W.
CFO
Grant
Option (right to buy)
500k
$5.98
$3M
03/16/2022
03/16/2022
Turner Heather D
Chief General Counsel
Grant
Option (right to buy)
300k
$5.98
$1.8M
03/16/2022
02/23/2022
Bishop Hans Edgar
Director
Exercise
Option (right to buy)
993.4k
$0.10
$99.3k
02/23/2022
02/11/2022
Lee Gary K.
Chief Scientific Officer
Grant
Option (right to buy)
800k
$6.04
$4.8M
02/11/2022
12/14/2021
FRIEDMAN CATHY
Director
Other (disposition)
Common Stock
3.8M
$0.00
$0
Lyell Investors, LLC
12/14/2021
12/14/2021
FRIEDMAN CATHY
Director
Other (acquisition)
Common Stock
218.7k
$0.00
$0
MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST
12/14/2021
09/13/2021
Homans Elizabeth
CEO
Grant
Option (right to buy)
1.4M
$16.05
$22M
09/13/2021
06/21/2021
NELSEN ROBERT
10% Owner
Conversion
Series A Convertible Preferred Stock
17.8M
$0.00
$0
ARCH Venture Fund IX Overage, L.P.
06/21/2021
06/21/2021
NELSEN ROBERT
10% Owner
Conversion
Series C Convertible Preferred Stock
435.1k
$0.00
$0
ARCH Venture Fund IX, L.P.
06/21/2021
06/21/2021
ARCH Venture Partners IX, LLC
10% Owner
Conversion
Common Stock
18.2M
$0.00
$0
ARCH Venture Fund IX, L.P.
06/21/2021
06/21/2021
ARCH Venture Partners IX, LLC
10% Owner
Conversion
Series A Convertible Preferred Stock
17.8M
$0.00
$0
ARCH Venture Fund IX, L.P.
06/21/2021
06/21/2021
ARCH Venture Partners IX, LLC
10% Owner
Conversion
series C Convertible Preferred Stock
435.1k
$0.00
$0
ARCH Venture Fund IX, L.P.
06/21/2021
06/21/2021
Bishop Hans Edgar
Director
Conversion
Common Stock
546.8k
$0.00
$0
06/21/2021
06/21/2021
Bishop Hans Edgar
Director
Conversion
Series A Convertible Preferred Stock
546.8k
$0.00
$0
06/21/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy